Title: hERG K(+) channels: structure, function, and clinical significance.

Authors: Jamie I Vandenberg, Matthew D Perry, Mark J Perrin, Stefan A Mann, Ying Ke, Adam P Hill

Journal, date & volume: Physiol. Rev., 2012 Jul , 92, 1393-478

PubMed link: http://www.ncbi.nlm.nih.gov/pubmed/22988594

Abstract
The human ether-a-go-go related gene (hERG) encodes the pore-forming subunit of the rapid component of the delayed rectifier K(+) channel, Kv11.1, which are expressed in the heart, various brain regions, smooth muscle cells, endocrine cells, and a wide range of tumor cell lines. However, it is the role that Kv11.1 channels play in the heart that has been best characterized, for two main reasons. First, it is the gene product involved in chromosome 7-associated long QT syndrome (LQTS), an inherited disorder associated with a markedly increased risk of ventricular arrhythmias and sudden cardiac death. Second, blockade of Kv11.1, by a wide range of prescription medications, causes drug-induced QT prolongation with an increase in risk of sudden cardiac arrest. In the first part of this review, the properties of Kv11.1 channels, including biogenesis, trafficking, gating, and pharmacology are discussed, while the second part focuses on the pathophysiology of Kv11.1 channels.